Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kristen Hege, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vall D´hebron University Hospital
Barcelona, Spain
- Hospital Virgen del Rocio Servicio de Hematologia
Seville, Spain
- Cedars Sinai Medical Center, Inflammatory Bowel Disease Center
Los Angeles, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Nyu School of Medicine
New York, New York, United States
- Cancer Center of the Carolinas
Greenville, South Carolina, United States
- Henry-Joyce Cancer Clinic
Nashville, Tennessee, United States
- Mary Crowley Cancer Research Centers - Medical City
Dallas, Texas, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2012
- Primary completion
- 11 Dec 2014
- Completion
- 11 Dec 2014
- Last update posted
- 12 Nov 2019
- Registered enrollment
- 76
- Registry id
- NCT01545947
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.